Page last updated: 2024-08-23

daunorubicin and Waldenstrom Macroglobulinemia

daunorubicin has been researched along with Waldenstrom Macroglobulinemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doria, G; Franchi, F; Konovalova, N; Pioli, C; Rossetti, R; Rossi Fanelli, F; Seminara, P; Tubani, L1
Bile, G; De Biasi, R1

Trials

1 trial(s) available for daunorubicin and Waldenstrom Macroglobulinemia

ArticleYear
Activity of a nitroxylated analog of daunorubicin, ruboxyl, in B-lymphoproliferative disorders.
    Acta haematologica, 2001, Volume: 105, Issue:2

    Topics: Aged; Aged, 80 and over; Animals; Antibiotics, Antineoplastic; B-Lymphocytes; Cells, Cultured; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Lymphocyte Count; Lymphoproliferative Disorders; Male; Mice; Mice, Inbred C57BL; Middle Aged; Multiple Myeloma; Pilot Projects; Remission Induction; Spleen; T-Lymphocytes; Waldenstrom Macroglobulinemia

2001

Other Studies

1 other study(ies) available for daunorubicin and Waldenstrom Macroglobulinemia

ArticleYear
[Daunoblastine in the treatment of leukemias and lymphoreticular neoplasms].
    Haematologica, 1969, Volume: 54, Issue:8

    Topics: Daunorubicin; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Waldenstrom Macroglobulinemia

1969